Acrigen Biosciences logo

Acrigen Biosciences

Biotech company developing technologies to improve efficiency and safety of CRISPR-Cas gene editing through anti-CRISPR proteins, also known as Acr proteins

1

Funding Rounds

Overview

Biotech company developing technologies to improve efficiency and safety of CRISPR-Cas gene editing through anti-CRISPR proteins, also known as Acr proteins

Industries

Acrigen Biosciences is active in the following industries: